Chelsea don’t have the option to re-sign the “skilled” player, according to Fabrizio Romano

tennis player

The option to re-sign AC Milan defender Fikayo Tomori is not available to Chelsea. Tomori was permanently sold by the Blues to Milan in 2021, and according to Fabrizio Romano’s Substack column, there is a no buy-back clause that his former club may activate. The Italian journalist began his statement with “My understanding is”, adding that Chelsea lacks a clause that would allow them to bring the center-half back to Stamford Bridge.

According to Fabrizio Romano, his market value has “more than doubled” since he left Stamford Bridge for the San Siro. Milan made a “smart” choice by signing the Englishman, considering the defender he has developed into.

Since joining Milan on an original loan agreement, Tomori has been a revelation for the team. Even club legends have been pleased by the 25-year-old, with Franco Baresi calling him a “skilful” defender after witnessing him play.

Chelsea have parted ways with Fikayo Tomori

Chelsea might still be kicking themselves for selling Tomori. The England international has improved as a football player.

But even without him, the Blues can survive. In the centre of the defence, they have youthful players as well as options. For instance, Benoit Badiashile is just a few years older than his Chelsea teammate Levi Colwill. Levi Colwill is 20-years old.

In other words, even if Chelsea did have the opportunity to re-sign Tomori, it is not a guarantee that they would because center-back is not really an issue position for Mauricio Pochettino at the moment.

Instead, the source of their issue is obvious up front. This season, the team has not scored enough goals, with the club’s first-choice striker Nicolas Jackson scoring just once. They should concentrate their efforts on that area, after all. It’s unlikely that adding another defender will advance them closer to the Champions League.

For more sports updates, follow us on Twitter.

For more sports updates, make sure to follow us on Twitter, Facebook, Instagram & LinkedIn.

To Top